| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.26 | 7e-10 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.25 | 8e-09 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.23 | 8e-08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.21 | 6e-07 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-06 |